225 related articles for article (PubMed ID: 33450878)
21. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
[TBL] [Abstract][Full Text] [Related]
22. Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells.
Wang Y; Liu Q; Liu Z; Li B; Sun Z; Zhou H; Zhang X; Gong Y; Shao C
Mutat Res; 2012 Jun; 734(1-2):20-9. PubMed ID: 22561209
[TBL] [Abstract][Full Text] [Related]
23. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells.
Yan K; Zhang C; Feng J; Hou L; Yan L; Zhou Z; Liu Z; Liu C; Fan Y; Zheng B; Xu Z
Eur J Pharmacol; 2011 Jul; 661(1-3):1-7. PubMed ID: 21545798
[TBL] [Abstract][Full Text] [Related]
24. FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis.
Naasani I; Seimiya H; Yamori T; Tsuruo T
Cancer Res; 1999 Aug; 59(16):4004-11. PubMed ID: 10463599
[TBL] [Abstract][Full Text] [Related]
25. Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways.
Puthdee N; Seubwai W; Vaeteewoottacharn K; Boonmars T; Cha'on U; Phoomak C; Wongkham S
Biol Pharm Bull; 2017; 40(6):751-757. PubMed ID: 28566619
[TBL] [Abstract][Full Text] [Related]
26. Targeting human telomerase in cancer therapy.
Huard S; Autexier C
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
[TBL] [Abstract][Full Text] [Related]
27. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
[TBL] [Abstract][Full Text] [Related]
28. Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells.
Xiao N; Chen S; Ma Y; Qiu J; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
Biochem Biophys Res Commun; 2012 Mar; 419(3):567-72. PubMed ID: 22369941
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
Li F; Dong X; Lin P; Jiang J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
[TBL] [Abstract][Full Text] [Related]
30. Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells.
Khaw AK; Yong JW; Kalthur G; Hande MP
Genes Chromosomes Cancer; 2012 Oct; 51(10):961-74. PubMed ID: 22736505
[TBL] [Abstract][Full Text] [Related]
31. Recent Advances in Nucleic Acid Binding Aspects of Berberine Analogs and Implications for Drug Design.
Bhowmik D; Kumar GS
Mini Rev Med Chem; 2016; 16(2):104-19. PubMed ID: 26349491
[TBL] [Abstract][Full Text] [Related]
32. Telomerase inhibitors as anticancer therapy.
Akiyama M; Hideshima T; Munshi NC; Anderson KC
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.
Gan Y; Lu J; Yeung BZ; Cottage CT; Wientjes MG; Au JL
AAPS J; 2015 Jan; 17(1):268-76. PubMed ID: 25425294
[TBL] [Abstract][Full Text] [Related]
34. Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
Morais KDS; Arcanjo DDS; de Faria Lopes GP; da Silva GG; da Mota THA; Gabriel TR; Rabello Ramos DDA; Silva FP; de Oliveira DM
Cell Biochem Funct; 2019 Jun; 37(4):273-280. PubMed ID: 31012504
[TBL] [Abstract][Full Text] [Related]
35. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.
Chen X; Zha GF; Wang JQ; Liu XH
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286
[TBL] [Abstract][Full Text] [Related]
36. Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo.
Chen C; Kuo YH; Lin CC; Chao CY; Pai MH; Chiang EI; Tang FY
PLoS One; 2020; 15(5):e0232832. PubMed ID: 32401800
[TBL] [Abstract][Full Text] [Related]
37. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer.
Su YH; Tang WC; Cheng YW; Sia P; Huang CC; Lee YC; Jiang HY; Wu MH; Lai IL; Lee JW; Lee KH
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2261-72. PubMed ID: 25982393
[TBL] [Abstract][Full Text] [Related]
38. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
Lu S; Obianom ON; Ai Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2869-2874. PubMed ID: 30037494
[TBL] [Abstract][Full Text] [Related]
39. Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells.
He W; Wang B; Zhuang Y; Shao D; Sun K; Chen J
J Pharmacol Sci; 2012; 119(4):341-8. PubMed ID: 22850597
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin induces G
Chen MJ; Cheng AC; Lee MF; Hsu YC
J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
